This inventor holds 2 USPTO granted patents. Top assignee: Pergamum Ab. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hindås, SE (2019)
- Hindas, SE (2021)
Company Filing History:
Years Active: 2019-2021
Title: Mattias Munnich: Innovator in Pharmaceutical Compositions
Introduction
Mattias Munnich is a notable inventor based in Hindas, Sweden. He has made significant contributions to the field of pharmaceutical compositions, particularly in the prevention of post-surgical complications. With a total of 2 patents, Munnich's work focuses on enhancing therapeutic effects through innovative formulations.
Latest Patents
Munnich's latest patents include compositions that contain hyaluronic acid aimed at preventing the formation of post-surgical scars and adhesions. These inventions relate to pharmaceutical compositions that enhance the therapeutic effect of biologically active peptides, especially those derived from human lactoferrin. The compositions are designed to be useful for the treatment and prevention of wounds, scars, and post-surgical adhesions.
Career Highlights
Munnich is associated with Pergamum AB, where he applies his expertise in developing advanced pharmaceutical solutions. His work has been instrumental in addressing critical issues related to surgical recovery and patient care.
Collaborations
Some of Munnich's coworkers include Margit Mahlapuu and Veronika Sjostrand, who contribute to the innovative environment at Pergamum AB.
Conclusion
Mattias Munnich's contributions to pharmaceutical compositions demonstrate his commitment to improving surgical outcomes through innovation. His work continues to impact the field positively, paving the way for advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile